Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine vs Meglumine Antimoniate for Pediatric Cutaneous Leishmaniasis
NCT00487253Phase 3Unknown
- Sponsor
- CIDEIM
- Start
- Jul 2007
- Primary completion
- Feb 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 3 trial of miltefosine in cutaneous leishmaniasis (CL), sponsored by CIDEIM. Status: unknown.
02
Drugs
miltefosine
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT00487253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00487253.